The role of the low density lipoprotein (LDL) receptor-related protein-1 (LRP-1) in pulmonary fibrosis
The role of the low density lipoprotein (LDL) receptor-related protein-1 (LRP-1) in pulmonary fibrosis
批准号:
171566970
负责人:
Professor Dr. Klaus T. Preissner
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2017-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal aims to explore the pathogenic role of the multifunctional scavenger and signaling receptor LRP-1 in lung fibrosis, and to apply new therapeutic strategies based on these investigations. In the first funding period, we gained important insight in the expression of LRP-1 and its impact on lung fibroblast activities under fibrotic conditions. We found strong down-regulation of LRP-1 expression in isolated lung fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) patients and in a respective animal model. LRP-1 deficiency markedly impacted fibroblast functions evidenced by altered adhesive and migratory properties, enhanced proliferation, increased production and altered composition of extracellular matrix (ECM) proteins, as well as diminished endocytosis of ECM proteins and haemostatic factors. Based on these findings the objectives of the proposal for the next funding period are (a) To causally link LRP-1 deficiency and the development of lung fibrosis in vivo by investigating newly generated conditional cell-specific LRP-1 knockout mice. (b) To identify factors, including microRNA(s), responsible for down-regulation of LRP-1 expression in fibrotic lungs. (c) To evaluate the consequences of LRP-1 deficiency for TGF-beta1-driven human lung fibroblast cellular activities (proliferation, ECM production, myofibroblast differentiation). (d) To identify the molecular mechanisms mediating LRP-1-regulated adhesive and migratory properties of lung fibroblasts. (e) To apply different approaches in order to prevent and/or reverse the remodelling process in animal models of lung fibrosis by systemic/local application of molecules modulating LRP-1 expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The influence of the extracellular RNA/RNase system on humoral and cellular reactions at the tumor-vessel interface
-
批准号:21994415
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Klaus T. Preissner
-
依托单位:
Dysregulation of pericullar proteolysis and growth factor functions in lung fibrosis: haemostasis-related pathomechanisms and new therapeutic modalities
-
批准号:5414892
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Professor Dr. Klaus T. Preissner
-
依托单位:
The role of endothelial cell receptors and bacterial products in Staphylococcus aureus endovascular infection and novel strategies for anti-inflammatory interventions
-
批准号:5408555
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Professor Dr. Klaus T. Preissner
-
依托单位:
The role of endothelial cell receptors and bacterial products in Staphylococcus aureus endovascular infection and novel strategies for anti-inflammatory interventions
-
批准号:5390120
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:Professor Dr. Klaus T. Preissner
-
依托单位:
国内基金
海外基金
登录
查看更多内容
骨髓微环境中正常造血干/祖细胞新亚群IL7Rα(-)LSK(low)细胞延缓急性髓系白血病进程的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王震毅
-
依托单位:
MSCEN聚集体抑制CD127low单核细胞铜死亡治疗SLE 的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:耿林玉
-
依托单位:
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
-
批准号:82371631
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:卢慕峻
-
依托单位:
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
-
批准号:82370780
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:夏术阶
-
依托单位:
Ni-20Cr合金梯度纳米结构的低温构筑及其腐蚀行为研究
-
批准号:52301123
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:郭晓开
-
依托单位:
新型PDL1+CXCR2low中性粒细胞在脉络膜新生血管中的作用及机制研究
-
批准号:82271095
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2022
-
负责人:柳夏林
-
依托单位:
CD9+CD55low脂肪前体细胞介导高脂诱导脂肪组织炎症和2型糖尿病的作用和机制研究
-
批准号:82270883
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:毕艳
-
依托单位:
CD21low/-CD23-B细胞亚群在间质干细胞治疗慢性移植物抗宿主病中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈小湧
-
依托单位:
探究Msi1+Lgr5neg/low肠道干细胞抵抗辐射并驱动肠上皮再生的新机制
-
批准号:82270588
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:吕聪
-
依托单位:
m6A去甲基化酶FTO通过稳定BRD9介导表观重塑在HIF2α(low/-)肾透明细胞癌中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54.7万元
-
批准年份:2021
-
负责人:徐丹枫
-
依托单位: